×
TR EN
Phase 1 Study of SUL-238 Was Started in Our Clinic
Phase 1 Study of SUL-238 Was Started in Our Clinic

The Phase 1 research study of the innovative research drug SUL-238, the first member of its class, to be conducted in healthy volunteers, has started in our clinic.

To access news in the press

Clinicaltrials

Haberturk

Ekonomim

Sulfateq

27 February 2024 Tuesday
0 total views